-+ 0.00%
-+ 0.00%
-+ 0.00%

Celldex Therapeutics 13G Filing Shows Point72 Asset Management Reported A 6.7% Stake In Co As Of July 2, 2025

Benzinga·07/10/2025 20:14:20
Listen to the news

- SEC Filing